Park KJ, Kong CS, Ohishi Y, Parra-Herran C. Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix. In : WHO Classification of Tumours of Editorial Board, eds. Female genital tumours. 5th ed. Lyon (France) : International Agency for Research on Cancer, 2020;374-375.
日本産科婦人科学会/日本病理学会(編):子宮頸癌取扱い規約 病理編 第5版 2022:43-44.
Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H. Trefoil factor family 2 protein : a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Virchows Arch 2019;474:79-86.
Asaka S, Nakajima T, Kugo K, Kashiwagi R, Yazaki N, Miyamoto T, et al. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ : gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type. Virchows Arch 2020;476:499-510.
Asaka S, Nakajima T, Ida K, Asaka R, Kobayashi C, Ito M, et al. Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status. Virchows Arch 2022;480:269-280.